Medicamente_care_contin_Valproat.pdf
Pseudoefedtrina_-_ATENTIONARI.pdf
Retinoizi_cu_administrare_orala-restrictii_pentru_prevenirea_expunerii_in_timpul_sarcinii.pdf
Informatii_privind_deficitul_de_aprovizionare_pentru_OZEMPIC_si_VICTOZA.pdf
In atentia profesionistilor din domeniul sanatatii - Informare_Bendamustină_Accord_25mg.pdf
In_atentia_profesionistilor_din_domeniul_sanatatii_-_BAXJECT_2_si_BAXJECT_HI-FLOW_2.pdf
Informatii_referitoare_la_Fluorochinolone.pdf
Instintare_catre_profesonistii_din_domeniul_sanatatii_cu_privire_la_PAZENIR_5mg-ml.pdf
Instintare_catre_profesonistii_din_domeniul_sanatatii_cu_privire_la_OZENPIC_injectabil.pdf
Comunicare_catre_profesionistii_din_domeniul_sanatatii_-_Cabazitaxel_Accord_30_mg.ml.pdf
Medicamente/Instiintare_-_Medicament_Xeljanz_(tofacitinib).pdf
Informatii_referitoare_la_Xeljanz_(tofacitinib).pdf
Tecentriq_(_atezolizumab)_Risc_de_reactii_adverse_cutanate_severe_(RACS).pdf